Relationship Between Clinical Status and Nerve Conduction Test Findings in Patients With Unilateral Hemiplegia
Prevalence of Peripheral Nerve Conduction Abnormalities and Their Association With Clinical Scores in Patients With Hemiplegia
1 other identifier
observational
72
1 country
1
Brief Summary
Stroke-related hemiplegia may be accompanied by peripheral nerve conduction abnormalities, which may contribute to motor impairment and functional limitations. However, the frequency of these abnormalities and their relationship with clinical status have not been fully characterized. This single-center observational study aims to evaluate the frequency of peripheral nerve conduction abnormalities identified by nerve conduction studies in patients with unilateral hemiplegia and to examine their association with motor and functional clinical assessment scores. The findings may contribute to a better understanding of peripheral nerve involvement in stroke rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2026
CompletedFirst Submitted
Initial submission to the registry
June 29, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedJuly 29, 2026
July 1, 2026
1.6 years
June 29, 2026
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association Between Peripheral Nerve Conduction Abnormalities and Clinical Assessment Scores
To evaluate the association between peripheral nerve conduction abnormalities identified by standardized nerve conduction studies and motor and functional outcome measures in patients with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke. Peripheral nerve conduction abnormalities identified by standardized nerve conduction studies will also be described.
Baseline
Secondary Outcomes (4)
Fugl-Meyer Assessment (FMA) Score (Upper and Lower Extremities)
Baseline
Functional Independence Measure (FIM) Score
Baseline
Timed Up and Go Test (TUG)
Baseline
Tetrax Fall Index
At study enrollment (baseline)
Study Arms (1)
Patients With Unilateral Post-Stroke Hemiplegia
Patients with unilateral post-stroke hemiplegia who underwent standardized nerve conduction studies and clinical assessments, including motor and functional outcome measures.
Interventions
Standardized motor and sensory nerve conduction studies were performed to evaluate peripheral nerve conduction abnormalities in patients with unilateral post-stroke hemiplegia. The test was used as a diagnostic assessment and was not part of a therapeutic intervention.
Eligibility Criteria
Adults with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke who were recruited from the Department of Physical Medicine and Rehabilitation at a single tertiary care center. All participants underwent standardized nerve conduction studies and clinical assessments according to the study protocol.
You may qualify if:
- Adults (≥18 years of age).
- Unilateral hemiplegia secondary to ischemic or hemorrhagic stroke, or intracranial hemorrhage.
- Ability to undergo standardized nerve conduction studies and clinical assessments.
- Provision of written informed consent.
You may not qualify if:
- Bilateral hemiplegia.
- Hemiplegia secondary to benign or malignant intracranial tumors.
- Upper or lower extremity fracture, amputation, skin lesions preventing electrophysiological testing, or diagnosed peripheral vascular disease.
- Concomitant neurological disorders that may affect motor function or peripheral nerve conduction (e.g., Parkinson's disease, multiple sclerosis, encephalitis).
- Contraindications to nerve conduction studies (e.g., cardiac pacemaker or inability to safely undergo the examination).
- Inability to cooperate with or tolerate nerve conduction studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başkent University Adana Dr. Turgut Noyan Application and Research Center
Adana, 01250, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2026
First Posted
July 6, 2026
Study Start
October 4, 2024
Primary Completion
May 20, 2026
Study Completion
June 24, 2026
Last Updated
July 29, 2026
Record last verified: 2026-07